What are the high risk factors for liver cancer All chronic liver diseases can develop into cirrhosis; however, there are not many causes for the occurrence of liver cancer. The most common chronic liver diseases in which liver cancer occurs are hepatitis B, followed by hepatitis C and alcoholic liver, and several other rare liver diseases. The vast majority of liver cancers in China are based on cirrhosis, or hepatitis with significant fibrosis, but a very small number can also occur in general hepatitis. Malignancies can be inherited, and liver cancer runs in families. Close relatives with malignancies, one serving more than three, and especially cirrhotic patients whose parents have liver cancer are at high risk. In the same proportion as all severe hepatitis B liver diseases, the incidence of liver cancer is several times higher in men than in women, with a male to female ratio of 4 to 8:1. Very few school-age children can also develop liver cancer, but cirrhosis and liver cancer occur most often in middle-aged and older patients with chronic hepatitis B. Information from long-term health insurance files in Taiwan shows that most patients with cirrhosis and liver cancer after middle age can be traced to mother-to-child infection in utero as young children. “Major triple-positive”, viral levels >7th degree copies/ml, no nucleoside analogs blocked at the end of pregnancy (most suitable with lamivudine until delivery discontinuation), and 10% of newborns will become chronic carriers or hepatitis despite standardized preventive vaccines and immunoglobulin injections. The incidence of hepatocellular carcinoma is significantly regional, with the southeastern coast of China being higher than the northwestern part of the country, roughly in line with the prevalence of hepatitis B virus, with several counties and cities (Haimen and Qidong in Jiangsu, Chongming in Zhejiang and Fusui in Guangxi) exceeding the prevalence of hepatitis B even more, with Haimen having the highest incidence in the world. Local incidence is also associated with some of its natural factors. In terms of cirrhosis and hepatocellular carcinoma groups, 80% belong to “small triple-positive”, which are mostly missed due to their hidden disease; in terms of individual cases, “large triple-positive”, middle-aged and elderly cirrhosis with high viral levels, in fact, the disease develops more than ” In fact, the progression of cirrhosis is more rapid than that of “small triple-positive” cirrhosis, and there is a greater risk. How to prevent liver cancer in people with hepatitis B infection at different stages of life In Taiwan, a study of universal hepatitis B vaccination in children reduced the incidence of liver cancer in the population. Thus, it is believed that: Hepatitis B vaccine is the only vaccine that can prevent Aizhong. Timely and standardized antiviral treatment for chronic hepatitis is actually aimed at preventing cirrhosis and liver cancer. Cirrhosis with positive virus and increased transaminases is active cirrhosis with developing disease, and the annual incidence of liver cancer is 4% if no antiviral treatment is given, and only enzyme-lowering drugs, liver-protective drugs or herbal medicines are used to moderate the disease. Nucleoside analogues are all effective in treatment and greatly reduce the incidence of hepatocellular carcinoma, but they do not completely prevent its occurrence. It rarely occurs in patients treated effectively with interferon, but cannot be prevented in patients with ineffective treatment.
Support Us
Discussion
Share your experience, or seek help from fellow patients.
